Osteoarthritis Trial, Recruiting (NCT06196567)

Osteoarthritis Trial, Recruiting NCT06196567 Sponsor: Chinese University of Hong Kong Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT06196567 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People over 50 years old (male or female) who have severe, end-stage knee arthritis and are waiting for a total knee replacement surgery
People who have already been scheduled for a total knee replacement at Prince of Wales Hospital
People who are able to take part in all study assessments and have agreed to participate in writing and verbally

Who may not be able to join:

People who have a connective tissue disorder or a muscle inflammation condition (such as myositis)
People who have previously had a hip or knee joint replacement
People who are currently unable to move around due to an acute condition, such as a recent hip fracture or a recent hospital stay
People with a history of substance abuse
People who have already had a total knee replacement on one knee
People who are unable to travel to appointments for the treatment sessions
People who have a condition affecting the nerves or muscles (such as a neuromuscular or neurodegenerative condition)
People who have a history of inflammatory arthritis (such as rheumatoid arthritis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Tim-Yun Ong, Chinese University of Hong Kong

Phone: 26364171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06196567

Sponsor: Chinese University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 26364171

More information: https://clinicaltrials.gov/study/NCT06196567

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People over 50 years old (male or female) who have severe, end-stage knee arthritis and are waiting for a total knee replacement surgery
People who have already been scheduled for a total knee replacement at Prince of Wales Hospital
People who are able to take part in all study assessments and have agreed to participate in writing and verbally

Who may not be able to join:

People who have a connective tissue disorder or a muscle inflammation condition (such as myositis)
People who have previously had a hip or knee joint replacement
People who are currently unable to move around due to an acute condition, such as a recent hip fracture or a recent hospital stay
People with a history of substance abuse
People who have already had a total knee replacement on one knee
People who are unable to travel to appointments for the treatment sessions
People who have a condition affecting the nerves or muscles (such as a neuromuscular or neurodegenerative condition)
People who have a history of inflammatory arthritis (such as rheumatoid arthritis)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

1 June 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Changes of knee muscle strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov